Recent Finacing
Recent Raise
Develops inhaled therapeutics using ARCUS dry‑powder pulmonary delivery; lead program CVT‑301 is inhaled levodopa for rapid relief of Parkinson’s OFF episodes via a reusable, breath‑actuated pocket inhaler.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors